Immunoproliferative Disorders  >>  Amgen  >>  Phase 2
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials		 012345678910
            
            
             
Blincyto (blinatumomab) / Astellas, Amgen           
          
            
             
Ibrance (palbociclib) / Pfizer           
          
            
             
Uplizna (inebilizumab-cdon) / Mitsubishi Tanabe, Amgen           
          
            
             
Enbrel (etanercept) / Pfizer, Amgen           
          
            
             
conatumumab (AMG 655) / Amgen           
          
            
             
dulanermin (AMG 951) / Amgen, Roche